Sjögren's syndrome classification

Revision as of 15:05, 23 June 2016 by Anthony Gallo (talk | contribs) (Categories)
Jump to navigation Jump to search

Sjögren's syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sjögren's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sjögren's syndrome classification On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sjögren's syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sjögren's syndrome classification

CDC on Sjögren's syndrome classification

Sjögren's syndrome classification in the news

Blogs on Sjögren's syndrome classification

Directions to Hospitals Treating Sjögren's syndrome

Risk calculators and risk factors for Sjögren's syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

Revised Classification Criteria for Sjogren's Syndrome[1]

A. Ocular symptoms: a positive response to at least one of the following questions:

1. Have you had daily, persistent, troublesome dry eyes for more than 3 months?
2. Do you have a recurrent sensation of sand or gravel in the eyes?
3. Do you use tear substitutes more than 3 times a day?

B. Oral symptoms: a positive response to at least one of the following questions:

1. Have you had a daily feeling of dry mouth for more than 3 months?
2. Have you had recurrently or persistently swollen salivary glands as an adult?
3. Do you frequently drink liquids to aid in swallowing dry food?

C. Ocular signs- that is, objective evidence of ocular involvement defined as a positive result for at least one of the following two tests:

1. Schirmer's test, performed without anaesthesia ( ≦5 mm in 5 minutes )
2. Rose bengal score or other ocular dye score ( ≧4 according to van Bijsterveld's scoring system )

D. Histopathology: In minor salivary glands (obtained through normal-appearing mucosa) focal lymphocytic sialoadenitis, evaluated by an expert histopathologist, with a focus score ≧1, defined as a number of lymphocytic foci (which are adjacent to normal-appearing mucous acini and contain more than 50 lymphocytes) per 4 mm2 of glandular tissue.

E. Salivary gland involvement: objective evidence of salivary gland involvement defined by a positive result for at least one of the following diagnostic tests:

1. Unstimulated whole salivary flow ( ≦ 1.5 ml in 15 minutes )
2. Parotid sialography showing the presence of diffuse sialectasias (punctate, cavitary,or destructive pattern ), without evidence of obstruction in the major ducts.
3. Salivary scintigraphy showing delayed uptake, reduced concentration and/or delayed excretion of tracer

F. Autoantibodies: presence in the serum of the following autoantibodies:

1. antibodies to Ro(SSA) or La(SSB) antigens, or both

Revised rules for classification

For primary SS

In patients without any potentially associated disease, primary SS may be defined as follows:

a. The presence of any 4 of the 6 items is indicative of primary SS, as long as either item 4 (Histopathology) or 6 (Serology) is positive.
b. The presence of any 3 of the 4 objective criteria items (that is, items 3, 4, 5, 6)
c. The classification tree procedure represents a valid alternative method for classification, although it should be more properly used in clinical-epidemiological survey.

For secondary SS

In patients with a potentially associated disease (for instance, another well defined connective tissue disease), the presence of item 1 or item 2 plus any two from among items 3, 4, and 5 may be considered as indicative of secondary SS.

Exclusive criteria

Past head and neck radiation therapy
Hepatitis C infection
Acquired immunodeficiency syndrome (AIDS)
Pre-existing lymphoma
Sarcoidosis
Graft-versus-host disease
Use of anticholinergic drugs (since a time shorter than 4-fold life of the drug)

References

  1. Ann Rheum Dis 2002; 61: 54-558

Template:WH Template:WS